October 13, 2021

BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization

August 18, 2021

BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

August 12, 2021

BioLineRx to Report Second Quarter 2021 Results on August 18, 2021